Skip to content

Dermatological application of a lipophilic extract of Viscum album- a multinational, retrospective case series study

Dermatological application of a lipophilic extract of Viscum album- a multinational, retrospective case series study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023229
Enrollment
50
Registered
2020-10-23
Start date
2020-11-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L57.0 C44.9

Interventions

Group 1: Patients with one of the three diagnoses mentioned above who have been treated with mistletoe resin cream

Sponsors

Lehrstuhl für Medizintheorie, Integrative und Anthroposophische MedizinUniversität Witten/Herdecke
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Actinic keratosis, cutaneous squamous cell carcinoma and basalioma 2) treatment of one of the three diagnoses between Apr 1st 2007 and July 1st 2020 3) age =18 years 4) legal capacity 5) voluntarily and written informed consent before the start of documentation 6) treatment with mistletoe resin cream in the relevant period of time

Exclusion criteria

Exclusion criteria: 1) Indications other than those mentioned above that have led to therapy with mistletoe resin cream 2) Use of another topical treatment or participation in another clinical trial during the treatment period with mistletoe resin cream or four weeks before 3) Clinically relevant concomitant conditions that excessively restrict the assessment of the effect and the tolerability of the mistletoe resin cream

Design outcomes

Primary

MeasureTime frame
Therapeutic effect: - clinical response according to RECIST at the last documented date Safety and tolerability : - incidence, frequency and severity of adverse drug reactions according to CTCAE V5 over the whole documented course of therapy

Secondary

MeasureTime frame
- Clinical response rate according to RECIST (complete or partial remission) at the last documented time - time from the start of therapy to best clinical response - cosmetic result from the treating physician`s point of view - patient satisfaction from the treating physician`s point of view - descriptive representation of typical/ unfavourable/ favourable courses

Countries

Austria, Germany, Switzerland

Contacts

Public ContactKarolina Königsberger

Lehrstuhl für Medizintheorie, Integrative und Anthroposophische MedizinUniversität Witten/Herdecke

Karolina.Koenigsberger@uni-wh.de0151 70817067

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026